LPL Financial’s ETF Series Solutions Trust Range Cancer Therapeutics ETF CNCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $128K | Sell |
|
|||||
|
2023
Q2 | $202K | Sell |
|
|||||
|
2023
Q1 | $207K | Sell |
|
|||||
|
2022
Q4 | $245K | Sell |
|
|||||
|
2022
Q3 | $280K | Hold |
|
|||||
|
2022
Q2 | $290K | Sell |
|
|||||
|
2022
Q1 | $347K | Buy |
|
|||||
|
2021
Q4 | $201K | Sell |
|
|||||
|
2021
Q3 | $306K | Sell |
|
|||||
|
2021
Q2 | $395K | Hold |
|
|||||
|
2021
Q1 | $371K | Sell |
|
|||||
|
2020
Q4 | $418K | Sell |
|
|||||
|
2020
Q3 | $466K | Sell |
|
|||||
|
2020
Q2 | $469K | Sell |
|
|||||
|
2020
Q1 | $358K | Buy |
|
|||||
|
2019
Q4 | $414K | Sell |
|
|||||
|
2019
Q3 | $397K | Sell |
|
|||||
|
2019
Q2 | $457K | Sell |
|
|||||
|
2019
Q1 | $652K | Sell |
|
|||||
|
2018
Q4 | $1.26M | Buy |
|
|||||
|
2018
Q3 | $1.19M | Buy |
|
|||||
|
2018
Q2 | $1.1M | Sell |
|
|||||
|
2018
Q1 | $3.49M | Buy |
|
|||||
|
2017
Q4 | $1.01M | Buy |
|
|||||
|
2017
Q3 | $848K | Buy |
|
|||||
|
2017
Q2 | $477K | Sell |
|
|||||
|
2017
Q1 | $553K | Sell |
|
|||||
|
2016
Q4 | $551K | Sell |
|
|||||
|
2016
Q3 | $934K | Sell |
|
|||||
|
2016
Q2 | $864K | Sell |
|
|||||
|
2016
Q1 | $1.9M | Buy |
|
|||||
|
2015
Q4 | $1.35M | Buy |
|